Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy (Q33365360)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy |
scientific article |
Statements
1 reference
Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy (English)
1 reference
Imran Haider
1 reference
Mary Cahill
1 reference
1 October 2004
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference